MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijc.30807

Медицинская библиотека · International journal of cancer · 2017

Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.

Zhang Qian, Dong Li, Hu Shangying, Feng Ruimei, Zhang Xun, Pan Qinjing, Ma Junfei, Zhang Li, Zhao Xuelian, Sankaranarayanan Rengaswamy, Qiao Youlin, Zhao Fanghui

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

E6 oncoprotein is a necessary agent of HPV driven oncogenic transformation. This study is aimed at evaluating the risk stratification potency of HPV 16/18 E6 oncoprotein (E6) as a triage method for HPV positivity. Moreover, it also acts as a predictor of cervical intraepithelial neoplasia grade 3 or worse (CIN3+). The screening cohort of 1,997 women was followed for a 15 year period in approximate five-year intervals. Participants were concurrently screened by HPV DNA testing (HC2), liquid based cytology (LBC), visual inspection with acetic acid (VIA) and were referred to colposcopy and biopsy if any tests reflected positive. E6 was performed on cervical samples collected from this cohort in 2005 and 2014. The ability of E6 to predict CIN3+ risk after the five- and ten-year interval was evaluated. Among HPV positive women in 2005, E6 indicated the lowest positive rate (9.9%) compared to LBC (48.4%) and VIA (28.0%), however, a higher prevalence rate (10.3%) and 10-year cumulative incidence rate (53.0%) of CIN3+ were detected among women who were E6 positive. Meanwhile, only 4.2% and 2.9% of women with abnormal LBC and positive VIA were diagnosed as prevalent CIN3+ in 2005, 23.0% and 16.5% developed to CIN3+ after year 10, respectively. Strong associations were found between precedent and subsequent HPV persistence and E6 oncoprotein expression (ORadjusted  = 40.0 and 21.2, respectively). E6 oncoprotein could serve as a low-cost, highly specific, strongly indicative point-of-care method in the triage and treatment of HPV positive women.

Для цитирования: Zhang Qian, Dong Li, Hu Shangying, Feng Ruimei, Zhang Xun, Pan Qinjing, Ma Junfei, Zhang Li, Zhao Xuelian, Sankaranarayanan Rengaswamy, Qiao Youlin, Zhao Fanghui. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.. International journal of cancer. 2017. DOI: 10.1002/ijc.30807.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.